Immune Checkpoint Inhibitors and CAR-T Cell Therapy: Thrombotic and Vascular Complications. acbr. 2025;9(5):359-364. Accessed September 20, 2026. https://www.fortunejournals.org/ojs/index.php/acbr/article/view/15130